Egypt’s metabolic dysfunction associated steatotic liver disease: Genetic and dietary nexus, shaping artificial intelligence driven healthier future

Table 4 Logistic regression analysis examining the association between various factors and metabolically dysfunction-associated steatotic liver disease in relation to participants’ age

Young population < 38 years	B	SE	OR	95%CI for OR	P value
BMI (reference normal BMI)					< 0.001
BMI (overweight vs normal BMI)	3.2	0.9	24	4.2-134	< 0.001
BMI (obese vs normal BMI)	3.5	0.9	32	5.5-183	< 0.001
Waist circumference (> 80 in female, > 94 in males)	1.2	0.6	3.4	1.1-11	0.042
HOMA-IR (elevated)	1.7	0.5	5.6	1.906	0.002
Old population ≥ 38 years
BMI (reference normal BMI)					< 0.001
BMI (overweight vs normal BMI)	1.3	0.5	3.8	1.5-9.8	0.006
BMI (obese vs normal BMI)	4.2	0.6	64.4	21-197.1	< 0.001
Elevated HOMA-IR	1.1	0.4	3.1	1.4-6.8	0.006
HbA1c (reference: Normal HBA1c ≤5.6)					0.045
HbA1c (prediabetic vs normal HbA1c)	1.3	0.5	3.6	1.3-9.9	0.013
HbA1c (diabetics vs normal HbA1c)	0.0	0.9	1.0	0.2-5.6	0.958

BMI: Body mass index; HBA1c: Glycated hemoglobin; HOMA-IR: Homeostasis Model Assessment of Insulin Resistance; OR: Odds ratio; CI: Confidence interval.